XML 24 R8.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statement Of Equity - USD ($)
$ in Millions
Total
Adoption of ASC 326
Cumulative Effect, Period of Adoption, Adjusted Balance
Common stock
Common stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional paid-in capital
Additional paid-in capital
Adoption of ASC 326
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Treasury Stock
Treasury Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Retained Earnings
Adoption of ASC 326
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated other comprehensive loss
Accumulated other comprehensive loss
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2019       50,000,000 50,000,000                    
Beginning balance at Dec. 31, 2019 $ 1,983 $ (5) $ 1,978 $ 0 $ 0 $ 2,068   $ 2,068 $ (1) $ (1) $ 323 $ (5) $ 318 $ (407) $ (407)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Capped Call (307)         (307)                  
Common Stock repurchased (54)               (54)            
Stock-based compensation — restricted shares issued 1         1                  
Common Stock issued — converted Preferred Shares 98         98                  
Dividends on preferred stock (3)                   (3)        
Net income (loss) (1)                   (1)        
Comprehensive income (loss) (61)                         (61)  
Ending balance (in shares) at Dec. 31, 2020       50,000,000                      
Ending balance at Dec. 31, 2020 1,651     $ 0   1,860     (55)   314     (468)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Capped Call (101)         (101)                  
Common Stock repurchased (in shares)       (1,000,000)                      
Common Stock repurchased (486)               (486)            
Stock-based compensation — restricted shares issued 1         1                  
Common Stock issued — converted Preferred Shares (3)         (3)                  
Dividends on preferred stock 0                            
Common Stock issued (in shares)       1,000,000                      
Common Stock issued 1,520         1,520                  
Unwind Capped Call 397         646     (249)            
Repurchase of 2028 Notes Conversion Option (1,484)         (1,484)                  
Net income (loss) 83                   83        
Comprehensive income (loss) $ (47)                         (47)  
Ending balance (in shares) at Dec. 31, 2021 50,418,980     50,000,000 50,000,000                    
Ending balance at Dec. 31, 2021 $ 1,531 $ (97) $ 1,434 $ 0 $ 0 2,439 $ (131) $ 2,308 (790) $ (790) 397 $ 34 $ 431 (515) $ (515)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Common Stock repurchased (147)               (147)            
Stock-based compensation — restricted shares issued 0               (1)            
Dividends on preferred stock 0                            
Common Stock issued           1                  
Shares granted (Note 18) 7               7            
Net income (loss) 482                   482        
Comprehensive income (loss) $ 51                         51  
Ending balance (in shares) at Dec. 31, 2022 50,257,751     50,000,000                      
Ending balance at Dec. 31, 2022 $ 1,827     $ 0   $ 2,309     $ (931) [1]   $ 913     $ (464)  
[1]
 
(*) As of December 31, 2022 the Company held 663,950 shares as treasury stock.